Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

Life is our mission.

Company.

Resuscitec GmbH is a medical technology company. We develop and distribute intelligent products for emergency medicine. With our activities we enable the restoration of patients’ health and thus make a sustainable contribution to improving their quality of life.

To this end, we have developed and approved the world’s first mobile system for controlled, targeted and personalized restoration of circulation outside the hospital.

We want to make a substantial contribution to saving lives with our products. The task of providing physicians, perfusionists and qualified specialists with an efficient tool for controlled, personalized whole-body reperfusion is therefore our company’s top priority.

Opening a new chapter in the history of resuscitation.

Chronology.

The history of our company represents the successful implementation ­of a therapeutic vision.

2010

Founding of the company as a spin-off of Freiburg University Hospital on the initiative of Univ.-Prof. Dr. Dr. h. c. Friedhelm Beyersdorf, Former Medical Director of the Clinic of Cardiovascular Surgery at The Medical Center – University of Freiburg

2012

Development and optimization of the CARL Therapy through application in large animal model, development and optimization of the CARL System

2014

Certification of the company according to EN ISO 13485

2014

Clinical proof of concept in the context of an application observation at the The Medical Center – University of Freiburg

2016

Participation in the EU program “Horizon 2020, Fast Track to Innovation Pilot” for the project CIRDinnova. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 730527.

2017

The company is awarded the Freiburg Innovation Prize

2019

Move to larger company premises in the BioTechPark Freiburg

2020

CE approval of the CARL System and start of the Post Market Clinical Follow-Up Study (PMCF) at four European centers

2021

Launch of the new brand identity

Establishment of the CARL Academy

Start of the FDA approval process and preparation for the US market entry

2022

Sales launch for the CARL System in Europe

Start of production and scale-up

Winning of the GDA and IF awards

2023

Certification according to regulation (EU) 2017/745

United for saving human lives.

 

Erich R. Reinhardt
Chairman of the Advisory Board

Thomas Kraft
Managing Director (CEO)

Christoph Benk
Managing Director (CTO)

Jörg Alexander Ronde
Managing Director (CFO)

Every life is unique, and every person is different.

Career.

The development of the CARL System from the first draft to market maturity was and is closely linked to the personal competence, enthusiasm and cooperativeness of our founders and employees. We are particularly proud of the professional and personal skills of our employees and work to maintain the high quality of interdisciplinary cooperation in our company. To this end, it is necessary to assess the respective competencies and skills precisely and to link them in the interest of all involved without restricting the subjective scope of action too much.

What applies to the patient-specific use of the CARL System therefore also applies to the working conditions in our company: We offer our employees, students and trainees flexible career and training opportunities with working hours adapted to the situation, performance-related remuneration and numerous promotion opportunities.

As a future-oriented company, we also attach particular importance to a collegial and appreciative working environment in which a dynamically motivated team focuses not only on the economic goals of our company, but above all on the well-being, safety and quality standards of the people who are to benefit from our work. The following aspects of our corporate culture should contribute to this: respect, reliability and quality assurance.

 

Interested in a smart working environment?

Vacancies.

Interested? Then find out about our current vacancies, bachelor’s/master’s theses and internships and apply at careers@resuscitec.de

We are looking forward to hearing from you!

HR Portal